Top PFO Specialists Perform First Human Placement of Sutura, Inc.'s SuperStitch EL To Close a Patent Foramen Ovale

FOUNTAIN VALLEY, CALIFORNIA--(MARKET WIRE)--Aug 27, 2007 -- Sutura, Inc. ("Sutura") (OTC BB:SUTU.OB - News), an innovative developer of minimally invasive vascular suturing devices, announced today the first use of the SuperStitch EL in a human patient to deliver a suture to the septum that separates the left and right atriums of the heart. Dr.'s Carlos E. Ruiz and Michael Mullen placed the suture into the septum to close a defect known as a Patent Foramen Ovale (PFO).